Xiaohua Wu

Shanghai Medical College of Fudan University

Also affiliated with University of Wollongong, Fudan University Shanghai Cancer Center, Daniel K. Inouye U.S. Pacific Basin Agricultural Research Center

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer”.

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.018

N/A

0.908DataRank · unranked

28 citations

Michael A. Bookman, Jalid Sehouli, Austin Miller, Richard T. Penson, Çağatay Taşkıran +20 more

820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC)

Annals of Oncology(2020)10.1016/j.annonc.2020.08.959

N/A

0DataRank · unranked

2 citations

Jianqing Zhu, Jun Wang, Zhongqiu Lin, Beihua Kong, Raymond Yin +15 more